KR101793918B1 - Sports beverage composition for improving exercise ability and enhancing immune function comprising polysaccharide from Astragalus membranaceus as effective component - Google Patents
Sports beverage composition for improving exercise ability and enhancing immune function comprising polysaccharide from Astragalus membranaceus as effective component Download PDFInfo
- Publication number
- KR101793918B1 KR101793918B1 KR1020170022438A KR20170022438A KR101793918B1 KR 101793918 B1 KR101793918 B1 KR 101793918B1 KR 1020170022438 A KR1020170022438 A KR 1020170022438A KR 20170022438 A KR20170022438 A KR 20170022438A KR 101793918 B1 KR101793918 B1 KR 101793918B1
- Authority
- KR
- South Korea
- Prior art keywords
- polysaccharide
- exercise
- sports
- beverage composition
- group
- Prior art date
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 81
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 81
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 235000006533 astragalus Nutrition 0.000 title claims abstract description 18
- 150000004676 glycans Chemical class 0.000 title claims abstract description 8
- 235000013361 beverage Nutrition 0.000 title claims description 35
- 241000045403 Astragalus propinquus Species 0.000 title claims description 4
- 230000036737 immune function Effects 0.000 title abstract description 15
- 230000002708 enhancing effect Effects 0.000 title description 6
- 235000011496 sports drink Nutrition 0.000 claims abstract description 24
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- 230000002829 reductive effect Effects 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000796 flavoring agent Substances 0.000 claims description 9
- 239000003381 stabilizer Substances 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 230000037147 athletic performance Effects 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 210000003743 erythrocyte Anatomy 0.000 claims description 5
- 235000003599 food sweetener Nutrition 0.000 claims description 5
- 239000003765 sweetening agent Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 239000002535 acidifier Substances 0.000 claims 1
- 229940095602 acidifiers Drugs 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 26
- 239000008103 glucose Substances 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- 241001061264 Astragalus Species 0.000 abstract description 4
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 2
- 238000010172 mouse model Methods 0.000 abstract 1
- 150000004804 polysaccharides Chemical class 0.000 description 77
- 235000001727 glucose Nutrition 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000013642 negative control Substances 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 11
- 230000009182 swimming Effects 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000003792 electrolyte Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 210000004698 lymphocyte Anatomy 0.000 description 7
- 230000001953 sensory effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 229920000591 gum Polymers 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- -1 bisbenthiamine Chemical compound 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 108010046377 Whey Proteins Proteins 0.000 description 4
- 102000007544 Whey Proteins Human genes 0.000 description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 229960004203 carnitine Drugs 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000020510 functional beverage Nutrition 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 235000021119 whey protein Nutrition 0.000 description 4
- 239000000811 xylitol Substances 0.000 description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 4
- 235000010447 xylitol Nutrition 0.000 description 4
- 229960002675 xylitol Drugs 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 240000000599 Lentinula edodes Species 0.000 description 3
- 235000001715 Lentinula edodes Nutrition 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000001329 hyperkeratotic effect Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 238000012453 sprague-dawley rat model Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000081841 Malus domestica Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 244000090599 Plantago psyllium Species 0.000 description 1
- 235000010451 Plantago psyllium Nutrition 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000889244 Synodontis membranacea Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- PSUBPFRWJHQJIA-UHFFFAOYSA-K [Ca+2].C(C=CC=CC)(=O)[O-].[Na+].C(C=CC=CC)(=O)[O-].C(C=CC=CC)(=O)[O-] Chemical compound [Ca+2].C(C=CC=CC)(=O)[O-].[Na+].C(C=CC=CC)(=O)[O-].C(C=CC=CC)(=O)[O-] PSUBPFRWJHQJIA-UHFFFAOYSA-K 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000004301 calcium benzoate Substances 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- 230000034149 carbohydrate storage Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002270 ergogenic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000009753 muscle formation Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/33—High-energy foods and drinks, sports drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
본 발명은 황기 유래의 다당체를 유효성분으로 함유하는 운동능력 개선 및 면역기능 증진용 조성물에 관한 것이다.The present invention relates to a composition for improving exercise performance and enhancing immune function, which comprises a polysaccharide derived from a hwanggi as an active ingredient.
우리나라 국민 한 사람이 한해 동안 마신 음료의 양은 1.5L 페트병을 기준으로 약 46개에 해당된다. 소비된 음료는 주로 탄산음료였고, 그 외 주스 음료가 주종을 이루는 것으로 나타났다. 한편, 기호성이 확실한 틈새시장의 기타 음료군은 2001년도에 전년 대비 약 43% 정도의 비약적인 시장 확대가 있었으며, 성장 속도가 탄산음료나 주스 시장에 비해 훨씬 빠른 것으로 조사되어, 연간 약 2,000억 원 규모의 시장으로 성장하고 있다. 특히, 기타 음료군에 속하는 기능성 음료는 국제적 행사 및 마케팅에 맞춰 시장이 대폭 증가하고 있는 추세로, 최근 생활 스포츠에 관한 관심의 증대와 함께 생활 음료로서 자리 매김하고 있다. 기능성 음료 중에 스포츠 음료는 땀을 많이 흘리는 운동을 하거나 중노동 또는 더운 환경에서 일하는 사람들에 있어서, 탈수현상을 막고, 체액의 전해질(이온)평형을 유지시키며, 체내의 탄수화물의 저장량의 현격한 감소를 억제하기 위한 음료로, 땀을 과도하게 흘리는 상황에서 물이나 전해질을 공급하기 위한 전해질 보충음료이다.The amount of beverages consumed by a Korean citizen per year is about 46 per 1.5L PET bottles. The consumed beverage was mainly carbonated beverage, and other juice beverage was found to be main. On the other hand, other beverages in niche markets, which are surely palatable, had a dramatic market expansion of about 43% in 2001 compared to the previous year, and their growth rate is much faster than the carbonated drinks and juice market. Of the market. In particular, functional beverages belonging to other beverages have been increasing in market in accordance with international events and marketing, and have recently become a living beverage with growing interest in living sports. In functional beverages, sports drinks prevent sweating, work in heavy or hot environments, prevent dehydration, maintain electrolyte (ion) balance of body fluids, and inhibit a significant reduction in carbohydrate storage in the body And is an electrolyte supplementary drink for supplying water or an electrolyte in a situation where sweat is excessively flowed.
시판되고 있는 대부분의 스포츠 음료의 성분을 보면 에너지 보충을 위하여 여러 종류의 당질들을 약 6~8%(w/v) 정도 포함하고 있으며, 상기 스포츠 음료에 포함된 당질의 농도가 8%(w/v)를 넘게 되면 음료의 장내 흡수 속도가 지연된다는 보고가 있다. 또한, 상기 스포츠 음료는 이온보충에 의한 전해질 평형을 위하여 나트륨, 칼륨, 마그네슘, 칼슘 등 전해질을 함유하고 있으며, 약간의 비타민 C 등도 포함되어 있는 경우도 있다. 또한, 상기 스포츠 음료를 포함한 기능성 음료는 시각적 청량감을 위하여 파랑, 노랑, 빨강 등 착색료가 첨가되는 경우도 있다. 상기 기능성 음료 특히, 스포츠 음료에 관한 연구는 최근 기존 이온 음료가 갖는 수분과 전해질 보급이라는 기본적인 기능 외에 근육 형성이나 운동력 향상 등 고기능성 역할이 추가된 고기능성 스포츠 음료를 제조하는 것에 대해 주로 진행되고 있다. 이러한 고기능성 스포츠 음료는 제품의 특성이나 용도에 따라 당질이나 전해질 이외에도 알긴산, 카르니틴, 타우린 또는 분지아미노산 등을 더욱 포함하기도 한다. 보다 구체적으로, 최근 개발되는 스포츠 음료는 단순히 갈증해소만을 만족시키는 단계에서, 피로회복 또는 지구력 증진 등의 다양한 기능을 갖고 있다. 즉, 상기 고기능성 스포츠 음료는 운동 전후 또는 운동 중 대량의 신속한 에너지공급이 요구되는 상황에서 에너지원으로 유용하고, 과도한 땀 생성으로 인해 급격하게 손실된 신체 내의 전해질과 수분을 공급할 수 있을 것이 요구된다. 따라서, 상기 고기능성 스포츠 음료는 전해질을 주성분으로 하고, 포도당, 과당 또는 올리고당 등 당 공급원인 감미료, 수용성 비타민 또는 아미노산 등을 포함한 것일 수 있다.Most of the commercially available sports drinks contain about 6 to 8% (w / v) of various kinds of saccharides for energy supplementation, and the concentration of saccharides contained in the sports drinks is 8% (w / v), there is a report that the intestinal absorption rate of beverage is delayed. In addition, the sports beverage contains electrolytes such as sodium, potassium, magnesium, and calcium for electrolyte balance by ion replenishment, and may contain some vitamin C or the like. In addition, the functional beverage including the sports beverage may be supplemented with a coloring agent such as blue, yellow, and red for a visual refreshing sensation. Studies on the above-mentioned functional beverages, in particular, sports beverages have been mainly conducted on the production of highly functional sports beverages in which a high functional role such as muscle formation and mobility improvement is added in addition to basic functions of water and electrolyte diffusion of existing ionic drinks . Such highly functional sports drinks may further contain alginic acid, carnitine, taurine, or branched amino acids in addition to saccharides and electrolytes depending on the characteristics and uses of the product. More specifically, recently developed sports drinks have various functions such as fatigue recovery or endurance enhancement at a stage of satisfying only thirst relief. That is, the high-functional sports beverage is useful as an energy source in a situation where a large amount of rapid energy supply is required before, during, or after exercise, and is capable of supplying electrolytes and moisture in a rapidly lost body due to excessive sweat generation . Accordingly, the highly functional sports beverage may be one containing an electrolyte as a main component and containing sweeteners such as glucose, fructose, and oligosaccharides, water-soluble vitamins, amino acids, and the like.
이와 관련하여, 최근에 스포츠 현장 등에서 영양소와 에너지를 빠르고 간편하게 효율적으로 얻기 위하여 만든 식품인 향상 보조제(Ergogenic Aids)가 경기력 향상을 위해 보조약물 또는 보조물질로 사용되고 있다. 그러나 상기 향상 보조제의 경우, 단백질 보조식품, 탄수화물 보조식품 또는 단백동화스테로이드(anabolic steroid)와 같은 근육증강제와 관련하여 문제가 될 여지가 있으므로, 이러한 문제점이 제기되지 않는 천연물 유래의 고기능성 스포츠 음료의 개발이 요구되고 있다.In this regard, Ergogenic Aids, a food that has recently been created to quickly and easily obtain nutrients and energy efficiently at sporting sites, is being used as an adjuvant or adjuvant to improve performance. However, in the case of the above-mentioned enhancing adjuvant, there is a problem in relation to a muscle enhancer such as a protein supplement, a carbohydrate supplements or anabolic steroid, so that a high-performance sports drink derived from a natural product Development is required.
한편, 한국등록특허 제0364000호는 스포츠 음료 조성물 및 이의 제조 방법을 개시하고 있으며, 한국등록특허 제0714464호는 스포츠 기능성 식품을 개시하고 있다. 하지만, 본 발명의 황기 유래의 다당체를 유효성분으로 함유하는 운동능력 개선 및 면역기능 증진용 스포츠 음료 조성물에 대해 아직까지 개시된 바가 없다.Korean Patent No. 0364000 discloses a sports beverage composition and a manufacturing method thereof, and Korean Patent No. 0714464 discloses a sports functional food. However, a sports beverage composition for improving exercise performance and for improving immune function, which contains the polysaccharide derived from the herbaceous period of the present invention as an active ingredient, has not yet been disclosed.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명에서는 황기 지상부 및 지하부로부터 다당체를 각각 추출하여 1:1의 중량비로 혼합한 후 동물모델 마우스에 경구투여한 결과, 상기 각각의 다당체 투여에 비해 운동 후 저하된 면역기능을 증진시키고, 지구력을 향상시킬 뿐만 아니라, 운동으로 인한 급격한 혈당 감소를 현저하게 억제하는 효과를 나타내는 것을 확인함으로써, 본 발명을 완성하였다.The present invention has been made in view of the above-mentioned needs. In the present invention, polysaccharides are extracted from the ground and underground parts of the hull, and mixed with each other at a weight ratio of 1: 1. The present invention has been accomplished by confirming that it exhibits an effect of not only enhancing immune function lowered after exercise and improving endurance but also remarkably suppressing rapid blood sugar reduction due to exercise.
상기 과제를 해결하기 위하여, 본 발명은 황기(Astragalus membranaceus) 유래의 다당체를 유효성분으로 함유하는 운동능력 개선 및 면역기능 증진용 스포츠 음료 조성물을 제공한다.In order to achieve the foregoing object, the present invention Astragali (Astragalus The present invention provides a sports beverage composition for improving exercise performance and enhancing immune function, comprising a polysaccharide derived from P. membranaceus as an active ingredient.
또한, 본 발명은 상기 음료 조성물을 포함하는 것을 특징으로 하는 운동능력 개선 및 면역기능 증진용 스포츠 음료를 제공한다.The present invention also provides a sports drink for improving exercise performance and improving immune function, which comprises the beverage composition.
본 발명은 황기 지상부 및 지하부로부터 다당체를 각각 추출하여 1:1의 중량비로 혼합한 후 동물모델 마우스에 경구투여한 결과, 운동 후 저하된 면역기능을 증진시키고, 지구력을 향상시킬 뿐만 아니라, 운동으로 인한 급격한 혈당 감소를 현저하게 억제시키므로, 스포츠 음료 조성물로 유용하게 이용될 수 있다.In the present invention, polysaccharides are extracted from the upper part of the hull and the lower part thereof, mixed at a weight ratio of 1: 1, and then orally administered to an animal model mouse. As a result, the immune function after exercise is lowered and the endurance is improved. And thus can be usefully used as a sports beverage composition.
도 1은 황기 지상부로부터 추출한 다당체(AMA), 황기 지하부로부터 추출한 다당체(AMR) 및 이들의 혼합물(AMA0.5+AMR0.5)의 경구투여 기간에 따른 유영한계 운동 효과를 확인한 결과이다. Control은 멸균 생리식염수를 경구투여한 음성대조군이며, AMA은 황기 지상부로부터 추출한 다당체를 경구투여한 실험군이며, AMR은 황기 지하부로부터 추출한 다당체를 경구투여한 실험군이며, AMA0.5+AMR0.5는 황기 지상부로부터 추출한 다당체 및 황기 지하부로부터 추출한 다당체를 혼합 경구투여한 실험군이다. *는 아무것도 투여하지 않은 음성대조군에 대비하여 황기 다당체 경구투여군의 유영한계 운동시간이 통계적으로 유의미하게 증가했다는 것을 의미한다.
도 2는 황기 지상부로부터 추출한 다당체(AMA), 황기 지하부로부터 추출한 다당체(AMR) 및 이들의 혼합물(AMA0.5+AMR0.5)의 경구투여하였을 때, 운동으로 인한 급격한 혈당 감소를 억제하는 효과를 확인한 결과이다. FIG. 1 shows the effect of swimming marginal exercise on oral administration of polysaccharide (AMA) extracted from the upper part of the hull, a polysaccharide (AMR) extracted from the lower part of the hull and a mixture thereof (AMA0.5 + AMR0.5). AMR is a group of oral administration of polysaccharides extracted from the basal part of the Yellow Ridge, and AMA0.5 + AMR0.5 is an experimental group of AMA0.5 + AMR0.5. The control group is a control group of oral administration of sterilized physiological saline, Mixed polysaccharide extracted from the above ground part and polysaccharide extracted from the lower part of the shiitake. * ≪ / RTI > means a statistically significant increase in swimming time limit of the oral administration group of erysipelas polysaccharide compared to the negative control group to which nothing was administered.
FIG. 2 shows the effect of suppressing rapid blood glucose decrease due to exercise when the polysaccharide (AMA) extracted from the upper part of the hull, the polysaccharide (AMR) extracted from the lower part of the hull and the mixture thereof (AMA0.5 + AMR0.5) The result is confirmed.
본 발명의 목적을 달성하기 위하여, 본 발명은 황기(Astragalus membranaceus) 유래의 다당체를 유효성분으로 함유하는 운동능력 개선 및 면역기능 증진용 스포츠 음료 조성물을 제공한다.In order to achieve the object of the present invention, the present invention provides a sports beverage composition for improving athletic performance and improving immune function, comprising a polysaccharide derived from Astragalus membranaceus as an active ingredient.
본 발명의 일 구현 예에 따른 스포츠 음료 조성물에서, 상기 면역기능 증진은 운동 후 저하된 면역기능을 증진시키는 것일 수 있으나, 이에 제한되지 않는다.In a sports beverage composition according to an embodiment of the present invention, the immune function enhancement may be to promote decreased immune function after exercise, but is not limited thereto.
또한, 상기 다당체는 황기 지상부로부터 추출된 다당체, 황기 지하부로부터 추출된 다당체 또는 이들의 혼합물일 수 있으며, 바람직하게는 황기 지상부로부터 추출된 다당체 및 황기 지하부로부터 추출된 다당체를 1~10:10~1의 중량비로 혼합한 것일 수 있으며, 더 바람직하게는 1:1의 중량비로 혼합한 것일 수 있으나, 이에 제한되지 않는다.The polysaccharide may be a polysaccharide extracted from the lower part of the stem, a polysaccharide extracted from the lower part of the stem, or a mixture thereof. Preferably, By weight, more preferably 1: 1 by weight, but the present invention is not limited thereto.
또한, 상기 황기 유래의 다당체 이외에 감미제, 풍미제, 미네랄, 비타민류, 보존제, 유화제, 안정제, 산미료 및 점증제 중에서 선택된 하나 이상을 포함하는 것일 수 있으나, 이에 제한되지 않는다.The polysaccharide may be at least one selected from sweeteners, flavors, minerals, vitamins, preservatives, emulsifiers, stabilizers, acidulants and thickeners in addition to the polysaccharides derived from the erythrocytes.
상기 감미제는 음료가 적당한 단맛을 나게 하는 양으로 사용될 수 있으며, 천연 또는 합성된 것일 수 있다. 천연 감미제는 옥수수 시럽 고형물, 꿀, 자일리톨, 수크로오스, 프룩토오스, 락토오스, 말토오스, 글루코오스 등의 당 감미제를 들 수 있다.The sweetener may be used in an amount that sweetens the beverage to a suitable sweet taste, and may be natural or synthetic. Natural sweeteners include sugar sweeteners such as corn syrup solids, honey, xylitol, sucrose, fructose, lactose, maltose, and glucose.
상기 풍미제는 맛이나 향을 좋게 하기 위하여 사용될 수 있는데, 천연의 것과 합성된 것 모두 사용될 수 있다. 천연의 것을 사용할 경우에 풍미 이외에 영양 강화의 목적도 병행할 수 있다. 천연 풍미제는 사과, 레몬, 감귤, 포도, 딸기, 복숭아 등에서 얻어진 것이거나 녹차잎, 둥굴레, 대잎, 계피, 국화 잎, 자스민 등에서 얻어진 것일 수 있다. 또한, 인삼(홍삼), 죽순, 알로에 베라, 은행 등에서 얻어진 것을 사용할 수도 있다. 천연 풍미제는 액상의 농축액이나 고형상의 추출물일 수 있다. 경우에 따라서 합성 풍미제가 사용될 수 있는데, 합성 풍미제는 에스테르, 알콜, 알데하이드, 테르펜 등의 형태의 것들이 이용될 수 있다.The flavoring agent may be used to improve taste or aroma, and both natural and synthetic flavoring agents may be used. When using natural ones, the purpose of nutritional fortification can be performed in addition to the flavor. The natural flavorings may be obtained from apples, lemons, citrus fruits, grapes, strawberries, peaches, etc., or obtained from green tea leaves, Aspergillus, Daegu, Cinnamon, Chrysanthemum leaves, Jasmine and the like. In addition, ginseng (red ginseng), bamboo shoots, aloe vera, obtained from the bank may be used. The natural flavoring agent may be a liquid concentrate or a solid form of extract. Synthetic flavoring agents may be used depending on the case. Synthetic flavoring agents such as esters, alcohols, aldehydes and terpenes may be used.
상기 미네랄은 칼슘, 마그네슘, 크롬, 코발트, 구리, 불소화물, 게르마늄, 요오드, 철, 리튬, 마그네슘, 망간, 몰리브덴, 인, 칼륨, 셀레늄, 규소, 나트륨, 황, 바나듐, 아연 등이 사용될 수 있다.The minerals may be calcium, magnesium, chromium, cobalt, copper, fluoride, germanium, iodine, iron, lithium, magnesium, manganese, molybdenum, phosphorus, potassium, selenium, .
상기 비타민류는 수용성 및 지용성의 각종 비타민류, 예를 들면 비타민 A(레티놀류), 비타민 B1(티아민), 비타민 B2(리보플라빈), 비타민 B3(니아신), 비타민 B6(피리독신), 비타민 B12(시아노코발라민), 비타민 C(아스코르브산), 비타민 D(콜레칼시페롤 등), 비타민E(토코페롤), 비스벤티아민, 니코틴산아미드, 판토텐산칼슘, 엽산, 비오틴, 중타르타 르산콜린 등을 예로 들 수 있다.The vitamins include various water-soluble and lipid-soluble vitamins such as vitamin A (retinol), vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B3 (niacin), vitamin B6 (pyridoxine), vitamin B12 Vitamin C (ascorbic acid), vitamin D (cholecalciferol, etc.), vitamin E (tocopherol), bisbenthiamine, nicotinic acid amide, calcium pantothenate, folic acid, biotin and heavy tartaric acid choline have.
상기 보존제는 소듐 소르브산칼슘, 소르브산나트륨, 소르브산칼륨, 벤조산칼슘, 벤조산나트륨, 벤조산칼륨, EDTA(에틸렌디아민테트라아세트산) 등을 들 수 있다. 상기 유화제는 아카시아검, 카르복시메틸셀룰로스, 잔탄검, 펙틴 등을 들 수 있다.Examples of the preservative include calcium sodium sorbate, sodium sorbate, potassium sorbate, calcium benzoate, sodium benzoate, potassium benzoate, and EDTA (ethylenediaminetetraacetic acid). Examples of the emulsifying agent include acacia gum, carboxymethyl cellulose, xanthan gum, pectin and the like.
상기 안정제는 물에 녹아서 점성을 나타내는 물질을 말한다. 상기 안정제는 본 발명에서 검류와 혼용되어 사용될 수 있다. 상기 안정제는 본 발명의 음료에서 점성을 부여할 수 있으며, 또한 유화 안정 효과를 가지고 올 수 있다. 상기 안정제의 예로는 특별히 이에 제한되지 않으나, 펙틴(pectin), 카라기난(carrageenan), 젤란검(gellan gum), 로커스트빈검(locustbean gum), 잔탄검(xanthan gum), 아가(agar), 곤약(konjac gum), 아라비아검(arabic gum), 풀루란검(pullulan gum), 차전자씨검(psyllium seed gum), 구아검(guar gum), 타마린드검(tamarind gum), 타라검(tara gum), 푸세아란검(furcellaran gum) 젤라틴(gelatin), 알긴산나트륨(sodium alginate) 또는 이의 조합일 수 있다.The stabilizer refers to a material that is dissolved in water to exhibit viscosity. The stabilizer may be used in combination with gum in the present invention. The stabilizer may impart viscosity to the beverage of the present invention and may also have an emulsion stabilizing effect. Examples of such stabilizers include, but are not limited to, pectin, carrageenan, gellan gum, locustbean gum, xanthan gum, agar, konjac, gum, arabic gum, pullulan gum, psyllium seed gum, guar gum, tamarind gum, tara gum, Furcellaran gum gelatin, sodium alginate, or a combination thereof.
상기 산미료는 연산, 말산, 푸마르산, 아디프산, 인산, 글루콘산, 타르타르산, 아스코르브산, 아세트산, 인산, 구연산 등을 들 수 있다. 이러한 산미료는 맛을 증진시키는 목적 이외에 미생물의 증식을 억제할 목적으로 음료 조성물이 적정 산도로 되도록 첨가될 수 있다.The acidulant may include math, malic acid, fumaric acid, adipic acid, phosphoric acid, gluconic acid, tartaric acid, ascorbic acid, acetic acid, phosphoric acid and citric acid. These acidulants may be added so that the beverage composition has a proper acidity for the purpose of inhibiting the growth of microorganisms other than the purpose of enhancing the taste.
상기 점증제는 현탁화 구현제, 침강제, 겔형성제, 팽화제 등을 들 수 있다.The thickening agent may be a suspending agent, a sedimentation agent, a gel-forming agent, a swelling agent, and the like.
또한, 본 발명은 상기 음료 조성물을 포함하는 것을 특징으로 하는 운동능력 개선 및 면역기능 증진용 스포츠 음료를 제공한다.
The present invention also provides a sports drink for improving exercise performance and improving immune function, which comprises the beverage composition.
이하, 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다.
Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are merely illustrative of the present invention and that the scope of the present invention is not limited thereto.
재료 및 방법Materials and methods
1. 황기 지상부 및 지하부로부터 다당체의 분리1. Separation of Polysaccharides from Above and Below
황기 지상부 및 지하부로부터 활성 다당체를 각각 분리하기 위해, 1kg의 황기 지상부 및 지하부 각각에 대해 20배 부피의 증류수를 첨가하여 분쇄하고 교반한 후, 증류수의 절반이 되는 양까지 가열하였으며, 이후 초기 동일한 부피가 되도록 증류수를 첨가하여 추출하고 흡인 여과한 후, 여과액을 합하여 감압농축하고 농축된 양의 5배의 에탄올을 첨가하여 침전시키고 남은 침전물을 대상으로 4℃에서 30분간 7,000rpm으로 원심분리하여 상등액과 잔사로 분리하였다. 상등액을 다시 동결 건조하여 열수추출물 분획을 얻었다. In order to separate the active polysaccharides from the upper and lower parts of the shorelines, 1 kg of distilled water having a volume of 20 times was added to each of the ground and underground portions of 1 kg, and the mixture was pulverized and stirred. The mixture was heated to half of the distilled water. . The filtrate was concentrated under reduced pressure, concentrated by adding 5-fold amount of ethanol and precipitated. The remaining precipitate was centrifuged at 7,000 rpm for 30 minutes at 4 ° C to obtain supernatant And the residue was separated. The supernatant was again lyophilized to obtain a hot-water extract fraction.
황기 지상부와 지하부 다당체의 당 구성을 확인하기 위하여, 얻은 시료에 대하여 중성당의 경우, 2.0M의 TFA(trifluoroacetic acid)로 121℃에서 1.5시간 동안 시료를 가수분해시킨 후 NaBH4를 이용하여 중성당을 알디톨(alditol)로 환원시키고, (CH3CO)2O를 이용하여 알디톨 아세테이트(alditol acetate) 유도체로 전환시켜 SP-2380 칼럼(0.2μm 필름, 0.25mm i.d×30m, Supelco, Bellefonte, PA, USA)이 장착된 GLC(HP-6890 II GLC, Hewlett-Packard, Palo Alto, CA, USA)로 구성당을 분석하였다. 또한, 산성당의 경우에 있어서, 0.1M의 TFA로 100℃에서 1시간 동안 가수분해시킨 후 NaBD4를 이용하여 중성당의 경우와 유사한 조건으로 알디톨 아세테이트(alditol acetate) 유도체로 전환시켜 GLC를 실시하였다. 구성당 분석을 위한 GLC의 온도조건은 주입기(injector) 250℃, 검출기(detector) 250℃이었고 칼럼은 60℃에서 1분이 경과하면 30℃/분의 속도로 220℃까지 상승시킨 후 12분간 유지하고 다시 8℃/분의 속도로 250℃까지 상승시켜 15분을 유지하며, 표준 당류의 머무름 시간(retention time)과 비교하여 시료 중의 구성당을 분석하고 구성당의 몰 백분율(mol%)은 각 피크(peak)들의 면적비와 구성당의 아세테이트(alditol acetate) 유도체의 분자량으로부터 계산한 후 몰비(molar ratio)로 표기하였다.
In order to confirm the above-ground and Astragalus Polysaccharide configured per the below-ground, if the neutral sugar with respect to the obtained sample, after hydrolysis of the sample for 1.5 h at 121 ℃ in a 2.0M TFA (trifluoroacetic acid) with NaBH 4 to the neutral sugars Reduction to alditol and conversion to alditol acetate derivatives using (CH 3 CO) 2 O was performed using SP-2380 column (0.2 μm film, 0.25 mm id × 30 m, Supelco, Bellefonte, PA , USA) were analyzed by GLC (HP-6890 II GLC, Hewlett-Packard, Palo Alto, CA, USA). In the case of acidic saccharides, GLC was carried out by converting sodium alginate to an alditol acetate derivative in the same conditions as in the case of neutral sugars by using NaBD 4 after hydrolysis with 0.1 M TFA at 100 ° C for 1 hour . The temperature condition of the GLC for the constitutional analysis was 250 ° C. for the injector and 250 ° C. for the detector. The column was elevated to 220 ° C. at a rate of 30 ° C./min after 1 minute at 60 ° C., The temperature was raised to 250 ° C at a rate of 8 ° C / min to maintain the temperature for 15 minutes. The constituent sugar in the sample was analyzed by comparing with the retention time of the standard saccharide, and the molar percentage (mol% peaks were calculated from molar ratios calculated from the area ratio of alditol acetate derivatives and the molecular weight of the alditol acetate derivative.
2. 실험동물에서의 2. In experimental animals 면역능Immunity 검정 black
(1) 황기 지상부 다당체 및 지하부 다당체 경구투여 및 (1) Oral administration of hyperpigmented polysaccharides and polysaccharides 림파구Lymphocyte 분리 detach
대한 바이오 링크에서 2014년 5월 22일에 6주령의 수컷 SD(Sprague-Dawley) 마우스를 입수하여 GLP 센터 SPF 실험동물실 내의 사육실 1에서 온도 23±3℃ 및 상대습도 50±20%를 유지하여 자동 명암 사이클 시스템에서 사육하였다. 황기 지상부 및 지하부로부터 분리한 각각의 다당체 및 이를 혼합하여 6주령의 SD 마우스를 대상으로 운동계열(E) 및 비운동계열(NE)로 나누고 각 군은 음성대조군(C), 황기 지상부 투여군(AMA), 황기 지하부 투여군(AMR), 황기 지상부 및 지하부 혼합 투여군(AMA0.5+AMR0.5) 및 스포츠음료 투여군(SPD)으로 5개의 처리군(총 10개 처리군)을 두었다. 각 처리군당 8마리로 구성하였으며, 음성대조군(C)으로 1.5㎖의 멸균 생리식염수(sterile normal saline)를 투여하였으며, 황기 지상부 다당체 투여군(AMA)은 마우스에 경구투여 시 용혈성(hemolytic acitivity)을 나타내지 않는 최대 농도인 500㎎/㎖를 처리농도로 정하였고, 황기 지하부 다당체 투여군(AMR)은 경구투여 시 면역증대 효과를 나타내는 최소 농도 10㎎/㎖를 처리농도로 정하였으며, 투여액량 10㎖/kg을 기준으로 일주일에 한번 조제하여 30일 동안 하루에 2~3회 경구 투여하면서 운동 검사를 실시한 실험동물로부터 림파구를 분리하였다. 양성대조군으로는 당을 고함유한 스포츠 음료(게토레이) 투여군(SPD)과 비교하였으며, 스포츠 이온음료의 경우, 액체 상태이므로 원체 그대로 투여액량에 맞게 준비하였다.On May 22, 2014, a 6-week-old male SD (Sprague-Dawley) mouse was obtained from Korea BioLink and maintained at a temperature of 23 ± 3 ° C and a relative humidity of 50 ± 20% And were raised in an automatic contrast cycle system. (E) and non-exercise (NE) groups, and each group was divided into the negative control group (C), the sham group (AMA) group (AMA0.5 + AMR0.5) and sports drink treatment group (SPD). The treatment group (10 treatments) was divided into two groups. Each group was treated with sterile normal saline (1.5 ml) as negative control (C). The group treated with polysaccharide (AMA) in the horseradish peroxidase group showed hemolytic acitivity when administered orally to mice (AMR) was administered at a concentration of 10 mg / ml, which is the minimum level of immunity-enhancing effect when administered orally, and the dose of the administered solution was 10 ml / kg , The mice were orally administered two to three times a day for 30 days, and lymphocytes were separated from the test animals. The positive control group was compared with the SPD (Sports Drink) group (SPD), and the sports ionic beverage was prepared in accordance with the amount of liquid administered as it was in a liquid state.
각 처리군에서의 림파구의 분리는 무균상태에서 HBSS(Hank's balanced salt solution, Sigma)를 첨가하여 마우스의 비장을 적출하고 스틸메쉬(steel mesh)를 통과시켜 균질화된 세포 상등액을 얻었으며, RBC 용해버퍼(red blood cell lysis buffer)를 이용하여 적혈구를 제거하였다. 여기에 다시 염화암모늄(ammonium chloride 0.8%, w/v)를 처리하여 적혈구(erythrocyte)를 분해시켰으며, 얻은 세포 부유물을 원심분리(380×g, 4℃ 및 10분)하였고, 형성된 펠렛(pellet)을 PBS로 3회 세척하고 1% 페니실린-스트렙토마이신(penicillin-streptomycin, Gibco Co, USA)과 10% FBS(Fetal bovine serum, Gibco Co, USA)이 첨가된 DMEM(Dulbecco's modified Eagle’s medium, Gibco Co, USA)을 사용하여 37℃ 및 5% CO2 조건에서 각각 배양하였다.
Separation of lymphocytes from each treatment group was carried out in a sterile state by adding HBSS (Hank's balanced salt solution, Sigma) to extract the spleen of a mouse and passing through a steel mesh to obtain a homogenized cell supernatant. RBC dissolution buffer (red blood cell lysis buffer). The cell suspension was centrifuged (380 × g, 4 ° C. and 10 minutes), and the formed pellet (pellet) was treated with ammonium chloride (ammonium chloride 0.8%, w / v) to decompose the erythrocyte. ) Was washed three times with PBS and then diluted with DMEM (Dulbecco's modified Eagle's medium, Gibco Co, USA) supplemented with 1% penicillin-streptomycin (Gibco Co, USA) and 10% FBS , USA) at 37 ° C and 5% CO 2 , respectively.
(2) 운동 수행(2) Performing exercises
시료 투입 및 한계운동 검사 전에 실험동물을 대상으로 하여 운동에 적응하도록 트레드밀(PBC47700 treadmill device; Coulbourn Instruments Co., USA)을 이용하여 7일 동안 15m/min으로 15분 동안 운동시켰으며, 트레드밀에는 전기충격장치를 부착하여 운동 동기를 부여할 수 있도록 하였다. 한계운동 검사 당일에 트레드밀에 경사를 10℃로 기울이고 30m/min으로 최대운동을 수행하게 하였다(최대 O2 소비의 약 70~75% 수준, 최대 O2 소비는 실험동물이 트레드밀에서 더이상 유지할 수 없을 때의 산소소비량).
The animals were allowed to move for 15 minutes at 15m / min for 7 days using a treadmill (PBC47700 treadmill device; Coulborn Instruments Co., USA) It is possible to attach the impact device to motivate the movement. Limited exercise test was performed up to exercise devoting 30m / min to tilt the treadmill the day to 10 ℃ (70 ~ 75%, the maximum O 2 consumption of maximum O 2 consumption of animals is not able to maintain longer on a treadmill Of oxygen consumption).
(3) CD4(3) CD4 ++ /CD8/ CD8 ++ 의 측정Measurement of
10% FBS를 함유한 PBS(phosphate buffer saline) 100㎖당 2×106 세포의 수준으로 부유된 비장 림프구에 피코에리트린(phycoerythrine) 항-마우스 CD4+(0.2㎍/ℓ×105 세포; PharMingen, San Diego, CA, USA) 또는 비오틴(biotin) 항-마우스 CD8+(0.2㎍/ℓ×105 세포; PharMingen)을 5㎕ 첨가하고, 4℃에서 30분간 배양하였으며, 이차항체(secondary antibody)는 스트렙타비딘-FITC(streptavidin-fluorescein isothiocyanate; Becton Dickinson) 또는 스트렙타비딘 피코에리트린(streptavidin phycoerythrine)을 첨가하였다. 배양된 림프구를 다시 10% FBS가 함유된 PBS를 첨가하여 300×g에서 5분간 3번 원심분리하였고, 염색된 림프구는 2% 파라포름알데히드(paraformaldehyde)로 고정시켰으며, 염색된 림프구의 부분 집합(subset)을 유세포분석기(FACScan; Becton Dickinson, Franklin Lakes, NJ, USA)로 측정하였다.
Phycoerythrine anti-mouse CD4 + (0.2 μg / l × 10 5 cells; PharMingen) was added to spleen lymphocytes suspended at a level of 2 × 10 6 cells per 100 ml of PBS (phosphate buffer saline) containing 10% FBS , 5 μl of biotin anti-mouse CD8 + (0.2 μg / ℓ × 10 5 cells; PharMingen) was added to each well and incubated at 4 ° C. for 30 minutes. Streptavidin-fluorescein isothiocyanate (Becton Dickinson) or streptavidin phycoerythrin were added. The cultured lymphocytes were further centrifuged at 300 × g for 3 min in PBS supplemented with 10% FBS. The stained lymphocytes were fixed with 2% paraformaldehyde, and a subset of lymphocytes stained (FACScan; Becton Dickinson, Franklin Lakes, NJ, USA).
3. 지구적 운동 능력 평가3. Assessment of global athletic performance
바이오 링크에서 2014년 4월 15일에 4주령의 ICR 웅성 마우스 80마리 구입하여 7일간 사육환경에 적응시킨 후, 각군 10마리씩 비운동계열에서 대조군(Nonexercise control, N-C), 황기 지상부 다당체 투여군(Nonexercise AMA, NE-AMA), 황기 지하부 다당체 투여군(Nonexercise AMR, NE-AMR) 및 황기 지상부와 지하부 다당체 혼합 투여군(Nonexercise AMA 0.5 and AMR 0.5, NE-AMA0.5+AMR0.5), 운동계열에서 대조군(Exercise control, E-C), 황기 지상부 다당체 투여군(Exercise AMA, E-AMA), 황기 지하부 다당체 투여군(Exercise AMR, E-AMR) 및 황기 지상부와 지하부 다당체 혼합 투여군(Exercise AMA 0.5 and AMR 0.5, E-AMA0.5+AMR0.5)으로 그룹화하였다. 마우스의 식이는 AIN-76A(Research diet, USA)를 급여하였으며, 황기 지상부 다당체 또는 황기 지하부 다당체 투여군은 1g/kg/day의 양으로, 황기 지상부 다당체 및 지하부 다당체 혼합처리의 경우에서는 최종 적용양이 단독처리와 동일한 양이 되도록 0.5g/kg/day으로 조정하였다. 투여는 매일 동일 시간에 경구 투여하였고, 대조군은 동일 부피의 증류수를 경구 투여하였다. 실험 마지막 날 경구 투여 후 3시간 전에 식이를 제거하고 한계 유영 운동 검사를 실시하고 운동검사 실시 이후 곧바로 대정맥에서 혈액을 채취하였으며, 3,000rpm에서 원심분리 후 혈청만 분리하였다. 혈청은 -70℃ 냉동고에 즉시 보관하여 실험에 이용하였다.On April 15, 2014, BioRink was purchased with 80 ICR male mice aged 4 weeks and adapted to the breeding environment for 7 days. Nonexercise control (NC), nonexercise (Nonexercise) (Nonexercise AMA 0.5 and AMR 0.5, NE-AMA 0.5 + AMR 0.5) and control group in the control group (nonexercise AMR, NE-AMR) (Exercise AMA, E-AMA), Exercise control (EC), Exercise AMA, E-AMR and E-AMR. AMA0.5 + AMR0.5). The dose of AIN-76A (Research diet, USA) was fed to the mouse, and the amount of 1 g / kg / day for the polysaccharide-treated polysaccharide and the polysaccharide-treated polysaccharide And adjusted to 0.5 g / kg / day so as to be the same amount as the single treatment. The doses were administered orally at the same time each day and the control group was orally administered the same volume of distilled water. On the last day of the experiment, the diet was removed 3 hours before the oral administration and marginal swimming exercise test was carried out. Blood was collected from the vena cava immediately after the exercise test and centrifuged at 3,000 rpm to separate the serum. Serum was immediately stored in a -70 ° C freezer and used for the experiment.
황기 지상부 및 지하부의 다당체 혼합투여에 따른 지구적 운동능력을 평가하기 위해, 유영 수조(90×45×45cm)를 이용하며 운동능력 측정 시에는 높이 35cm까지 물을 채운 후 수온을 34℃로 유지하여 실험하였다. 운동부하는 물표면의 유속으로 조절하며, 표면유속은 전압조절기가 연결되어 있는 펌프 및 물 유랑계(type F45500, Blue white Co, Westminster, CA, USA)를 이용하여 물의 순환을 통해 조절하였다. 본 실험 시작하기 전 1주간의 예비 사육기간 중 수영에 적응시키기 위해, 2번(7L/min, 15min)의 적응 수영을 하게 한 후, 2번의 지구적 운동 능력을 측정하여 운동계열군의 평균 유영 시간이 같도록 하였으며, 대조군, 황기 지상부 다당체, 지하부 다당체 및 황기 지상부 다당체와 지하부 다당체 혼합투여군으로 나누었다. 운동실험 3시간 전부터 금식시키고, 운동 시행 2시간 전에 시료를 경구 투여하였다. 모든 유영운동 능력 측정시각은 오후 1시부터 5시까지 실시하였으며, 지구적 운동 능력의 측정은 한계치 수영, 즉 마우스가 물 표면으로 7초간 올라오지 못하는 시점을 한계점으로 하여 마우스 수영 시작 시점부터 한계점까지의 총 시간을 측정하였다.
(90 × 45 × 45cm) was used to evaluate the global exercise ability according to the mixed administration of polysaccharide in the upper part of the upper part of the stem and the lower part of the stem, water was filled up to 35 cm in measuring the exercise ability, and the water temperature was maintained at 34 ° C. Respectively. The surface velocity was controlled by water circulation using a pump and a water flow meter (type F45500, Blue White Co, Westminster, Calif., USA) to which a voltage regulator was connected. In order to adapt to swimming during the 1 week preliminary breeding period before the experiment, 2 (7 L / min, 15 min) adaptive swimming was performed, and 2 global exercise capacities were measured, The time was the same, and the control group, the Shijiazhuang terrestrial polysaccharide, the underground polysaccharide, and the Shiga terrestrial polysaccharide were mixed with the ground polysaccharide. The subjects were fasted 3 hours before the exercise and 2 hours before the exercise. All swimming ability was measured from 1 pm to 5 pm and the global athletic ability was measured from the starting point of the mouse swimming to the threshold point Was measured.
4. 한계 유영운동 동안의 실험동물의 혈당 측정 4. Blood glucose measurement of experimental animals during marginal swimming exercise
한계 유영운동 동안의 꼬리 정맥혈을 가지고 혈당(glucose)을 측정하였다. 혈당은 한계 유영운동 전, 운동 15분 전, 한계치 운동, 운동 후 15분 후 및 운동 후 60분에 꼬리 정맥혈을 회수하여 혈당 측정기(ARKRAY, Kyoto, Japan)를 이용하여 측정하였다.
Glucose was measured by tail vein blood during marginal swimming exercise. Blood glucose was measured using a blood glucose meter (ARKRAY, Kyoto, Japan) before the marginal swimming exercise, 15 minutes before the exercise, the threshold exercise, 15 minutes after the exercise, and 60 minutes after the exercise.
실시예Example 1. 본 발명의 황기 유래의 다당체 처리에 따른 CD4 1. The polysaccharide-derived polysaccharide-treated CD4 + + 및 CD8And CD8 + + 세포수Cell number 증가와 CD4 With increasing CD4 ++ /CD8/ CD8 + + 비율 유지효과 Ratio maintenance effect
본 실시예 1에서는 황기 지상부 및 지하부 다당체를 투여한 실험동물에서 한계운동 후, 적출된 비장에서의 CD4+ 및 CD8+의 세포수를 측정하고 양성대조군으로 사용된 기존 스포츠음료와 비교분석하였다. 그 결과, 하기 표 1에 개시한 바와 같이 CD4+의 경우, 비운동계열의 음성대조군(NE-C)에서 19.3%를 수준을 나타낸 반면, 운동계열의 음성대조군(E-C)에서는 16.1%로 감소하였으며, CD8+의 경우에서도 음성대조군의 비운동계열에서 15.1%, 운동계열에서 8.8%로 급격히 감소하는 경향을 나타내었다. 반면에, 황기 지상부 다당체 투여군, 황기 지하부 다당체 투여군 및 황기 지상부 다당체 및 지하부 다당체 혼합 투여군의 경우, 운동계열 및 비운동계열 모두에서 CD4+ 및 CD8+의 세포수를 증대시켰으며, 특히 음성대조군(E-C)에서 운동 후 급격히 감소하였던 CD8+의 세포수를 높은 수준으로 유지시키는 결과를 나타내었다. CD4+/CD8+ 비율의 경우, 음성대조군(NE-C)에서 비운동시 약 1.33의 비율을 나타낸 반면, 동일 군에서 운동 후에는 1.86으로 증가하였다. 음성대조군(E-C)의 경우, 운동에 의해 급격한 면역 저하를 나타내는 반면, 황기 지상부 다당체 투여군, 황기 지하부 다당체 투여군 및 황기 지상부 다당체 및 지하부 다당체 혼합 투여군의 경우, 비운동계열에서 CD4+/CD8+ 비율이 각각 1.06, 1.18 및 1.19였으며, 운동 이후에도 1.14, 1.08 및 1.05를 나타내어 비운동시 및 운동 이후에도 세포독성 T 림프구(CD8+)로의 분화를 촉진시켜 CD8+ 세포 수를 증대시킴으로써 운동 후 증가되었던 CD4+/CD8+ 비율을 감소시켜 변화를 일정하게 유지시켜주는 효과를 나타내었다.In Example 1, the number of CD4 + and CD8 + cells in the spleen after the marginal exercise was measured and compared with the existing sports drinks used as the positive control group in the experimental animals receiving the aerial part and the underground polysaccharide. As a result, as shown in Table 1 below, the CD4 + level was reduced to 19.3% in the negative control group (NE-C) while it decreased to 16.1% in the negative control group (EC) , And CD8 + , 15.1% in the non - exercise group and 8.8% in the exercise group in the negative control group. On the other hand, the number of CD4 + and CD8 + cells was increased in both the exercise and non-exercise groups in the case of the administration of the polysaccharide-containing polysaccharide in the hwanggi group, the polysaccharide group in the hwanggi- ) Maintained high levels of CD8 + cells that were rapidly decreased after exercise. For the CD4 + / CD8 + ratio, the ratio of unexcited at the negative control (NE-C) was about 1.33, while it increased to 1.86 after exercise in the same group. On the other hand, the negative control group (EC) showed a rapid decrease in immunity while the ratio of CD4 + / CD8 + in the non-exercise series was higher in the case of the group administered with the hyperkeratotic polysaccharide, the group with the basal polysaccharide and the group with the basal polysaccharide (CD4 + / CD8 +), which was increased after exercise, by promoting differentiation into cytotoxic T lymphocyte (CD8 + ) and increasing the number of CD8 + cells after emptying and after exercise, showing 1.04, 1.06, 1.18 and 1.19 after exercise + Ratio to keep the change constant.
NE-C는 비운동계열의 마우스에 멸균 생리식염수를 투여한 실험군; NE-AMA는 비운동계열의 마우스에 황기 지상부 다당체를 투여한 실험군; NE-AMR는 비운동계열의 마우스에 황기 지하부 다당체를 투여한 실험군; NE-AMA0.5+AMR0.5는 비운동계열의 마우스에 황기 지상부 다당체 및 황기 지하부 다당체를 혼합투여한 실험군; NE-SPD는 비운동계열의 마우스에 스포츠음료(게토레이)를 투여한 실험군; E-C는 운동계열의 마우스에 멸균 생리식염수를 투여한 실험군; E-AMA는 운동계열의 마우스에 황기 지상부 다당체를 투여한 실험군; E-AMR는 운동계열의 마우스에 황기 지하부 다당체를 투여한 실험군; E-AMA0.5+AMR0.5는 운동계열의 마우스에 황기 지상부 다당체 및 황기 지하부 다당체를 혼합투여한 실험군; E-SPD는 운동계열의 마우스에 스포츠음료(게토레이)를 투여한 실험군.
NE-C was an experimental group in which non-exercise-type mice were administered sterile saline; NE-AMA is an experimental group in which non-exercise group mice were treated with erbotropic topical polysaccharide; NE-AMR is an experimental group in which a non-exercise-type mouse was administered with a basal polysaccharide of the Hwanggi group; NE-AMA0.5 + AMR0.5 was an experimental group in which the non-exercise group mice were mixed with the basal polysaccharide and the basal polysaccharide; NE-SPD is an experimental group in which non-exercise-type mice were given a sports drink (Gatorade); EC was an experimental group in which exercise-type mice were administered sterile physiological saline; E-AMA is an experimental group in which exercise-type mice were treated with a hyperkeratotic polysaccharide; E-AMR is an experimental group in which exercise-type mice were administered a basal polysaccharide of Hwanggi group; E-AMA0.5 + AMR0.5 was an experimental group in which exercise-type mice were mixed with a basidiomycetous polysaccharide and a basidiomycetes; E-SPD is an experimental group that sports drinks (Gatorade) were administered to exercise-type mice.
실시예Example 2. 본 발명의 황기 유래의 다당체 처리에 따른 지구적 유영능력 개선 효과 2. Effect of the present invention on the effect of polysaccharide treatment on the global swimming ability
마우스를 대상으로 황기 지상부 다당체, 지하부 다당체 및 황기 지상부 다당체와 지하부 다당체 혼합물을 각각 투여한 후 무산소성 역치(anaerobic threshold) 이하의 운동 강도인 유속 7L/분의 운동강도하에서 운동을 시켜 유영 한계치까지의 운동시간을 측정하였다. 그 결과, 도 1에 개시한 바와 같이 실험기간 동안 운동능력 향상능은 대조군과 비교하여 황기 지하부 다당체 투여군(AMR)에서 운동 21 및 28일에 각각 52% 및 68%(22.7분 및 29.8분), 황기 지상부 다당체 투여군(AMA)에서는 각각 61% 및 64%(18.4분 및 20.8분) 향상되어짐을 알 수 있었으며, 황기 지상부 및 지하부 다당체의 투여가 운동능력 향상에 유의한 영향을 미친다고 말할 수 있겠다. 또한, 동일한 투여양을 기준으로 황기 지상부와 지하부를 혼합하여 투여한 군(AMR0.5+AMA0.5)에서 최종 28일에 동일 기간 내 황기 지하부 단독투여군의 운동능력 향상능 68%에 비해 황기 지상부 및 지하부 다당체 혼합 투여군은 75%의 운동능력 향상능을 나타내어 황기 지상부 및 지하부 다당체 혼합투여를 장기적으로 적용하는 경우 더 효과적인 운동능력 향상 효과를 나타낼 것으로 판단된다.
The mouse was administered with a mixture of a hyperkeratotic polysaccharide, a polysaccharide of the underground polysaccharide and a polysaccharide of the underground polysaccharide and a polysaccharide of the underground polysaccharide, and then exercised under the exercise intensity of the flow rate of 7 L / min, which is the anaerobic threshold, The exercise time was measured. As a result, as shown in FIG. 1, the ability to improve the performance during the experimental period was 52% and 68% (22.7 minutes and 29.8 minutes) on the 21st and 28th days of exercise on the AMR of the basal polysaccharide group, And 61% and 64% (18.4 minutes and 20.8 minutes), respectively. In addition, the administration of polysaccharide in the upper part of the shrub and lower part of the body had a significant effect on the improvement of the athletic performance. On the other hand, in the group administered with the same dosage amount (AMR0.5 + AMA0.5) mixed with the lower part of the basal area, And underground polysaccharide mixed group showed 75% of the ability to improve the athletic performance. Therefore, it is considered that the long-term application of the mixture of the topical and the basal polysaccharide of the hwanggi group will show a more effective exercise capacity improvement effect.
실시예Example 3. 본 발명의 황기 유래의 다당체 처리에 따른 혈당 유지효과 3. Effect of the present invention on blood sugar-holding effect according to polysaccharide treatment
안정 시 근육은 유리 지방산을 주 에너지원으로 사용하나, 운동이 시작되면 포도당을 주로 이용한다. 따라서 운동 중인 근육은 근육 내에 존재하는 당원의 분해를 통해 생산된 포도당과 혈중 포도당을 필요한 에너지원으로 사용한다. 따라서 운동 시에는 혈중 글루코오스 양이 줄어들게 되는데 한계시점에서 감소되는 글루코오스의 수준은 운동시간이 길어질수록 근육에서 더 많은 글루코오스를 소모하게 되고, 결과적으로 간과 근육에 있는 글리코겐이 글루코오스로 활발히 분해된다. At rest, muscles use free fatty acids as their primary source of energy, but they use glucose mainly when exercise begins. Therefore, the muscles in motion use glucose and blood glucose produced through decomposition of the glycans in muscle as necessary energy sources. Therefore, the amount of glucose in the blood during exercise decreases. The level of glucose, which is decreased at the limit of time, consumes more glucose in the muscles as the exercise time becomes longer. As a result, the glycogen in the liver and muscles is actively decomposed with glucose.
황기 지상부 및 지하부의 단독 투여 및 혼합 투여 후 혈액 중 글루코오스의 농도를 측정한 결과, 도 2에 개시한 바와 같이 대조군에서는 운동 한계시간부터 운동 후 휴식 15분 후까지 혈액 중 급격한 글루코오스의 농도 감소가 발생하였고, 황기 지하부 다당체 투여군(AMR) 및 황기 지상부 다당체 투여군(AMA)의 경우에서도 동일한 양상을 나타내었으나, 운동 한계시간에는 글루코오스 농도 감소 수준이 대조군에 비하여 약 50% 수준으로 낮았다. 또한, 황기 지상부 및 지하부 혼합투여군(AMA0.5+AMR0.5)의 경우, 운동한계시간부터 운동 후 휴식 15분까지 혈액 중 급격한 글루코오스의 농도 감소를 현저하게 감소시킨 것을 확인할 수 있었다.
As shown in FIG. 2, the concentration of glucose in the blood after the single administration and the mixed administration of the aerial part and the underground part of the hull was measured. In the control group, rapid decrease in glucose concentration occurred in the blood from the exercise time limit to 15 minutes after the exercise (AMR) and hyperglycosylated polysaccharide (AMA) group. However, the decrease of glucose concentration in the exercise time limit was about 50% lower than that of the control group. In addition, it was confirmed that in the case of the mixed administration group (AMA0.5 + AMR0.5) of the aerial part and the underground part, rapid decrease of glucose concentration in the blood was remarkably reduced from the exercise limit time to the resting time of 15 minutes after exercise.
실시예Example 4. 본 발명의 황기 유래 다당체를 함유하는 스포츠 음료 시제품 관능평가 4. Sensory evaluation of prototype sports drinks containing the polysaccharide of the present invention
본 실시예 4에서는 운동 후 저하된 면역기능 증진효과가 확인된 황기 지상부 다당체 및 황기 지하부 다당체를 혼합하여 시제품 제작에 사용하였다. 시제품 제작용 운동능력 향상 및 운동 후 저하된 면역기능 증진 효능 평가에서 사용된 황기 지상부 다당체 및 지하부 다당체 획득 방법을 통하여 준비하며, 스포츠 음료 제조 전까지 밀봉하여 냉장 보관하였으며, 황기 지상부 또는 지하부 다당체를 희석 농축액으로 제조하였다. 음료 시제품의 영양적인 면과 관능적인 면을 향상시키기 위하여 각 농축시료에 첨가제로서, 카르니틴, 유청 단백질(whey protein, 음료 불투명도를 고려 첨가 비율 설정 → 0.02 g, 운동기능 향상효과, 근육형성, 면역증강 효과 등), 비타민 C, 비타민 B(니아신), 사과농축액, 자일리톨, 구연산 및 포도당을 첨가하여 100㎖의 음료로 제조하였다. 음료 제조는 정제수에 유청 단백질을 넣고 20분간 균질(수화)시키고 88℃에서 2분간 열처리하였다. 카르니틴, 사과농축액, 황기 지상부 다당체, 황기 지하부 다당체, 비타민 B(니아신), 자일리톨, 구연산, 사과산 및 포도당을 혼합하여 95℃까지 중탕 가열한 후 88℃까지 방냉시켰다. 비타민 C와 유자코튼을 넣고, 용기에 충진하여 얼음물에서 냉각시켜 제조하였다. pH는 3~4가 되도록 조정하였다. 사전 시음을 통해, 총 26개의 레시피를 제작하였으며, 그 중 3개를 선택하여 음료를 제조하였다. 제조된 음료의 각 성분 함량은 하기 표 2에 개시한 바와 같으며, 옅은 황백색의 불투명 음료로 제조되었으며 시제품 간 외관의 큰 변화는 확인되지 않았다. In Example 4, a combination of a shiitake polysaccharide and a shiitake polysaccharide having reduced immune function after exercise were mixed and used in the production of a prototype. This study was carried out to obtain the aerobic polysaccharide and the polysaccharide of underground polysaccharide which were used in the evaluation of efficacy of immune function improvement after exercise. . In order to improve the nutritional and sensory aspects of beverage prototypes, carnitine, whey protein, beverage opacity was added to each concentrate as an additive. Effect, etc.), vitamin C, vitamin B (niacin), apple concentrate, xylitol, citric acid and glucose. In the beverage preparation, whey protein was added to purified water and homogenized (hydrated) for 20 minutes and heat-treated at 88 ° C for 2 minutes. Carnitine, apple juice concentrate, hwanggi topical polysaccharide, basal polysaccharide, vitamin B (niacin), xylitol, citric acid, malic acid and glucose were mixed and heated to 95 ℃ and allowed to cool to 88 ℃. Vitamin C and citron were added, filled in a container and cooled in ice water. The pH was adjusted to 3-4. A total of 26 recipes were prepared through pre - tasting, and 3 of them were selected to produce beverages. The contents of each ingredient in the prepared beverage were as shown in Table 2 below and were made into a pale yellowish white opaque beverage and no large change in appearance between the prototypes was observed.
(whey protein)Whey protein
(whey protein)
황기 다당체 함유한 스포츠 음료는 A, B 및 C 3가지로 제조하여 관능검사를 실시하였다. 관능검사는 국내에서 선행된 차류 및 음료 대상으로 실시한 관능검사에 대한 방법을 이용하여 항목자료를 구성하였다. 제품에 대하여 선발된 20대 남 및 여 28명을 대상으로 관능평가를 실시하였다. 각 시료에 대해 7점 기호척도(1점: 대단히 싫다, 4점: 좋지도 싫지도 않다 및 7점: 대단히 좋다)를 이용하여 외관 기호도, 향 기호도 및 전체적인 기호도를 평가하고, 세부 항목으로 단맛 정도, 신맛 정도, 쓴맛 정도 및 후미 정도에 대해 7점 기호척도에 의해 평가하여 평균과 표준편차를 통해 결과를 도출하였다. 그 결과, 하기 표 3에 개시한 바와 같이 각 음료에 대해 7점 기호도로 평가하였을 때, 외관, 색, 향, 단맛, 신맛, 쓴맛, 후미 및 전체적인 기호도 모두 B의 점수가 가장 높고, 외관 및 쓴맛을 제외한 항목에선 A가 가장 낮았다. 음료의 성분 함량의 차이가 없으며, 선호도 조사와 비교하였을 때 B가 스포츠 음료로 제조 및 이용하기에 가장 적합하였다.The sports drinks containing hwanggi polysaccharide were prepared by three kinds of A, B and C and sensory tests were conducted. The sensory test was conducted by using the method of sensory test conducted in domestic and imported drinks and drinks. Sensory evaluation was performed on twenty - eight male and female twenty - eight selected for the product. For each sample, the appearance preference degree, incense degree degree, and overall degree of likelihood were evaluated using the 7-point symbol scale (1 point: very disliked, 4 points: neither good nor disliked and 7 points: very good) , Sourness degree, bitterness degree and posterior degree were evaluated by the 7 - point symbol scale, and the results were derived by means of the mean and standard deviation. As a result, as shown in the following Table 3, the score of B was the highest in appearance, color, flavor, sweet taste, sour taste, bitter taste, aesthetic taste, overall taste and overall taste, and appearance and bitterness A was the lowest in the items except for. There was no difference in the content of beverages, and B was the most suitable for making and using sports drinks when compared with preference survey.
Claims (6)
2) 상기 단계 1)의 황기 지상부 추출물 및 지하부 추출물을 각각 감압농축한 후, 수득한 황기 지상부 농축액 및 지하부 농축액 각각에 대하여 5배의 에탄올을 첨가하여 각각의 침전물을 수득하는 단계; 및
3) 상기 단계 2) 이후에, 상기 수득한 각각의 침전물을 원심분리하여 상등액을 수득하는 단계;를 포함하는 방법으로 추출된 황기(Astragalus membranaceus) 지상부 유래 다당체 및 지하부 유래 다당체를 동일 중량비로 혼합한 혼합물을 유효성분으로 함유하는 운동능력 개선용 스포츠 음료 조성물.1) Astragalus membranaceus : a step of adding 20 times volume of water to each of the above and below the ground, pulverizing, heating and extracting;
2) concentrating the extracts of the light yellow, ground and bottom part of the step 1) under reduced pressure, respectively, adding 5-fold amount of ethanol to each of the obtained concentrated sulfuric acid and the concentrate of the underground part to obtain respective precipitates; And
3) After step 2), each of the obtained precipitates is centrifuged to obtain a supernatant, and Astragalus membranaceus polysaccharides derived from the above ground and polysaccharides derived from the ground are mixed at the same weight ratio A sports beverage composition for improving exercise ability containing a mixture as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170022438A KR101793918B1 (en) | 2017-02-20 | 2017-02-20 | Sports beverage composition for improving exercise ability and enhancing immune function comprising polysaccharide from Astragalus membranaceus as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170022438A KR101793918B1 (en) | 2017-02-20 | 2017-02-20 | Sports beverage composition for improving exercise ability and enhancing immune function comprising polysaccharide from Astragalus membranaceus as effective component |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101793918B1 true KR101793918B1 (en) | 2017-11-07 |
Family
ID=60385005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170022438A KR101793918B1 (en) | 2017-02-20 | 2017-02-20 | Sports beverage composition for improving exercise ability and enhancing immune function comprising polysaccharide from Astragalus membranaceus as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101793918B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101493895B1 (en) * | 2014-02-10 | 2015-02-17 | 강원대학교산학협력단 | Polysaccharide extracted from above ground part of Astragalus membranaceus and uses thereof |
-
2017
- 2017-02-20 KR KR1020170022438A patent/KR101793918B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101493895B1 (en) * | 2014-02-10 | 2015-02-17 | 강원대학교산학협력단 | Polysaccharide extracted from above ground part of Astragalus membranaceus and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103110162B (en) | Vegetable protein drink containing seeds of paeonia suffruticosa and preparation method of drink | |
CN103284165A (en) | Applications of algae in solid beverage and formulae | |
CN105876548A (en) | Fruit and vegetable drink with maca and radix ginseng, method for preparing fruit and vegetable drink and application thereof | |
CN102845795A (en) | Functional health-care beverage | |
CN101773269A (en) | Glossy ganoderma and agaric biological health drink | |
CN107568675A (en) | Russule honey ointment and its preparation technology | |
CN102228103A (en) | Lemon and chrysanthemum tea beverage and preparation method thereof | |
CN109699745A (en) | A kind of fucosylated oligosaccharide baby formula milk powder and preparation method thereof | |
CN101199358A (en) | Zymotic jujube vinegar beverage | |
CN104757632A (en) | Fructose rosa roxburghii juice suspending beverage and production method thereof | |
CN1446468A (en) | Instant medlar coffee | |
CN105062773B (en) | A kind of Composite fermentation type agate card health drink and its production technology | |
CN104872775A (en) | Compound type weight-losing solid beverage with green-tea polysaccharide and application of compound type weight-losing solid beverage | |
KR101793918B1 (en) | Sports beverage composition for improving exercise ability and enhancing immune function comprising polysaccharide from Astragalus membranaceus as effective component | |
CN105248625A (en) | Fresh keeping method for citruses | |
CN105595129A (en) | Sea-buckthorn composite concentrated solution capable of promoting growth of children and protecting eyesight and preparation method thereof | |
CN108813492A (en) | A kind of shaddock tremella jam with the effect of filling blood | |
CN100556319C (en) | Fruit enriched type hazelnut beverage and preparation method thereof | |
CN107996901A (en) | A kind of cicada fungus sea-buckthorn sports drink and preparation method thereof | |
CN1122211A (en) | Snow glossy ganoderma health beverage | |
KR101541638B1 (en) | Energy drink composition comprising fruits and vegetables extracts | |
CN114366775A (en) | Eye-protecting nutrient solution | |
CN108606064A (en) | A kind of milk product of freeze-drying wolfberry fruit powder | |
CN107095305A (en) | A kind of preparation method of okra colloid polyoses oral liquid | |
CN102239918A (en) | Fruit juice milk beverage containing red barberry, red date and milk and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |